Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5483523 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL1828702 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5490493 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL1519575 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL1827086 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5485779 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5488963 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL5490761 | 1.00 | THRB (0.44) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL935232 | 0.98 | THRB (0.41) | THRBLMNAALKBH5SUCNR1EGLN1 | |
| SCHEMBL9438155 | 0.93 | LMNA (0.40) | THRBLMNAALKBH5SUCNR1EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4527829-A1 | PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS | Chiron AS (NO) | 2025-03-26 | — | — | EP | claimed |
| EP-4677665-A1 | COMPONENT FOR AN ELECTROCHEMICAL CELL, REDOX FLOW CELL, FUEL CELL, AND ELECTROLYSER | Schaeffler Technologies AG & Co. KG (DE) | 2026-01-14 | — | — | EP | disclosed |
| US-20250388807-A1 | DISPLAY DEVICE | SHARP DISPLAY TECHNOLOGY CORP (JP) | 2025-12-25 | — | — | US | disclosed |
| US-20250110101-A1 | PER AND POLYFLUOROALKYL SUBSTANCE MEASUREMENT | DEXSIL CORPORATION (US) | 2025-04-03 | — | — | US | disclosed |
| EP-4527829-A1 | PROCESS FOR THE PURIFICATION OF PERFLUOROALKYL ACIDS | Chiron AS (NO) | 2025-03-26 | — | — | EP | disclosed |
| CN-118184238-B | Impervious waterproof fiber reinforced concrete and preparation method thereof | 衢州交通建筑工业化有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-118930152-A | Impervious waterproof fiber reinforced concrete and preparation method thereof | 曜之岩(广州)建材科技有限公司 | 2024-11-12 | — | — | CN | disclosed |
| US-12109812-B2 | Ink jet printing method and ink jet printing apparatus | SEIKO EPSON CORPORATION (JP) | 2024-10-08 | — | — | US | disclosed |
| CN-118702320-A | Method for removing fluorine telomeric carboxylic acid in water by two-step method | 山东省城市供排水水质监测中心 | 2024-09-27 | — | — | CN | disclosed |
| WO-2024183856-A1 | COMPONENT FOR AN ELECTROCHEMICAL CELL, REDOX FLOW CELL, FUEL CELL, AND ELECTROLYSER | Schaeffler Technologies AG & Co. KG (DE) | 2024-09-12 | — | — | WO | disclosed |
| US-5268456-A | Immobilizing a protein; bonding to ligand | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-12-07 | — | — | US | disclosed |
| US-5268307-A | Dissolving a perfluoroisocyanate emulsifier with ligand or binder | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-12-07 | — | — | US | disclosed |
| EP-0571832-A2 | Imides and their salts and their use as surface active agents | BAYER AG (DE) | 1993-12-01 | — | — | EP | disclosed |
| EP-0246103-B1 | BIOAFFINITY AND ION EXCHANGE SEPARATIONS WITH LIQUID EXCHANGE SUPPORTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-08-25 | — | — | EP | disclosed |
| EP-0252736-B1 | PROCESS FOR PREPARING FLUORINE-CONTAINING CARBOXYLIC ACID ESTER | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-07-24 | — | — | EP | disclosed |
| US-4992104-A | Redox telomerization of acylamide and polyfluorinated acrylate with carbon tetrachloride | SOCIETE ATOCHEM (FR) | 1991-02-12 | — | — | US | disclosed |
| US-4855487-A | Process for preparing fluorine-containing carboxylic acid ester | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0252736-A2 | Process for preparing fluorine-containing carboxylic acid ester | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1988-01-13 | — | — | EP | disclosed |
| EP-0246103-A2 | Bioaffinity and ion exchange separations with liquid exchange supports | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-19 | — | — | EP | disclosed |
| US-3963776-A | Amine fluoroacylimide surfactants | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388807-A1 | DISPLAY DEVICE | CFL1, PFN1, VCL | THRB 2019/4885LMNA 2815/4885ALKBH5 2563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.